Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
359 Cards in this Set
- Front
- Back
which bronchus is more likely to have aspiration?
|
right bronchus
it is more vertical with the trachea than is the left bronchus |
|
what is an acinus?
|
terminal respiratory unit, composed of respiratory bronchioles, alveolar ducts, and alveolar sacs
about 7mm in diameter distal to terminal bronchiole |
|
components of the alveolar septum from blood to air
|
endothelial cells with basement membrane
thin portions: basement membranes of endothelium and epithelium are fused thicker portions: basement membranes are separated by interstitial space with a few elastic fibers, collagen, fibroblasts, mast cells, and rare lymphocytes |
|
type I pneumocytes
|
very flat
cover 95% of surface more vulnerable to injury |
|
type II pneumocytes
|
rounder
produce, contain, and secrete surfactant can proliferate and repair and give rise to type I pneumocytes |
|
what perforates alveolar walls? why is this clinically important?
|
pores of Kohn
permit passage of bacteria and exudate between adjacent alveoli |
|
agenesis of lungs
|
can involve 1 lobe, 1 lung, or both lungs
if unilateral, other lung can enlarge often causes other abnormalities, especially with the right lung (cardiac anomalies) |
|
what are the causes of lung hypoplasia?
|
anything that causes oligohydramnios (e.g. Potter's sequence)
diaphragmatic hernia **abnormalities that compress the lung** |
|
congenital lung cysts
|
single/multiple abnormal detachment of a fragment of primitive foregut, ranging in size from microscopic to 5cm, usually located adjacent to bronchi or bronchioles
most are bronchogenic cysts consists of bronchial epithelium (pseudostratified columnar epithelium) filled with mucus or air |
|
what are the complications of congenital lung cysts?
|
infection
rupture into bronchi (causing hemorrhage and/or hemoptysis) rupture into pleural cavity (causing pneumothorax and/or interstitial emphysema) |
|
bronchopulmonary sequestration
|
congenital mass of lung tissue without normal connection of airway
blood supply arises from aorta or branches (not pulmonary circulation) extralobar vs. intralobar |
|
extralobar bronchopulmonary sequestration
|
congenital mass of lung tissue without the normal connection to an airway located external to the lung (anywhere in the thorax or mediastinum)
blood supply arises from aorta or branches (not pulmonary circulation) found as abnormal mass lesions in infants look for other congenital anomalies |
|
intralobar bronchopulmonary sequestration
|
congenital mass of lung tissue without the normal connection to an airway located within the lung
blood supply arises from aorta or branches (not pulmonary circulation) causes infection and bronchiectasis found in older children in association with recurrent infections or bronchiectasis |
|
atelectasis
|
incomplete expansion of a neonatal lung or collapse of a previously inflated lung
if substantial, can reduce oxygenation and predispose to infection |
|
resorption (obstruction) atelectasis
|
collapse of a previously inflated lung caused by complete obstruction of an airway; causes resorption of residual oxygen
blood flow remains normal, but lung volume diminishes mediastinum may shift towards the obstructed lung if a substantial portion of lung is involved usual cause is excess secretions or exudate in small bronchi |
|
what are the causes of resorption (obstruction) atelectasis?
|
excess secretions or exudate in small bronchi
- asthma, bronchitis, bronchiectasis - foreign body aspiration - post-operative obstruction b/c pt doesnt want to cough up obstructive material (less frequent b/c of inc. use of laprascopic surgery) - tumors are an unusual cause (they usually do not completely obstruct the bronchus |
|
compression atelectasis
|
pleural cavity is either partially or completely filled with a substance (usually fluid) which compresses the lung
causes: pus accumulation; CHF; tumors causing effusions; stab/penetration wounds; elevation of diaphragm mediastinum shifts away from the involved lung |
|
what are the causes of compression atelectasis?
|
pus accumulation
congestive heart failure (most common) neoplasms causing effusions (fluid is more bloody than that seen in CHF) stab wounds or other external penetration (if it nics an intercostal artery) elevation of the diaphragm (diaphragmatic hernia) |
|
what is the most common cause of compression atelectasis?
|
congestive heart failure (CHF)
|
|
contraction atelectasis
|
localized or general fibrosis (restrictive lung diseases) in the lung prevents full lung expansion
only type of atelectasis that is irreversible |
|
how is an atelectasis reversible?
|
except for contraction atelectasis, they (resorption and compression) can be reversed by removal of the obstructive or compressive agent
|
|
what is the complication for atelectasis?
|
infections
|
|
what are the two basic mechanisms that cause pulmonary edema?
|
1) hemodynamic abnormalities - increased hydrostatic pressure, e.g. left sided CHF
2) increased capillary permeability b/c of microvascular injury - endothelial/epithelial injury |
|
pulmonary edema caused by hemodynamic abnormalities
|
most common cause: increased hydrostatic pressure (i.e. caused by lt-sided CHF
gross: wet, heavy lungs, especially in the basal parts of the lower lobe clinical: impaired respiratory function and predisposition to infection |
|
microscopic morphology of pulmonary edema caused by hemodynamic abnormalities
|
pink, frothy fluid in alveolar spaces
congested capillaries hemosiderin-laden macrophages (heart-failure cells) with chronic disease, see fibrosis and thickening of alveolar wall/septa hemosiderin + fibrosis = brown induration over time |
|
what are heart failure cells?
|
hemosiderin-laden macrophages in the lungs caused by ingestion of iron from trapped red blood cells
|
|
pulmonary edema caused by increased capillary permeability
|
microvascular injury to endothelial or alveolar epithelial cells leads to edema
protein and fluid are leaked into the interstitium and subsequently into alveoli contributes to ARDS when diffuse |
|
acute lung injury
|
noncardiogenic pulmonary edema
abrupt onset of hypoxemia and diffuse infiltrates in absence of cardiac failure characterized by rapid onset of severe resp. infufficiency, cyanosis, severe refractory hypoxemia; may progress to extrapulmonary multisystem organ failure if severe, called ARDS; if no underlying cause, called acute interstitial pneumonia mortality is about 40% |
|
causes for acute lung injury/ARDS/acute interstitial pneumonia
|
direct lung injury
diffuse infections oxygen toxicity inhalation of toxins or other irritants aspiration of gastric contents systemic causes: septic shock, traumatic shock, severe pancreatitis, burns, complicated cardiac surgeries, hemodialysis, or narcotic OD |
|
pathogenesis of acute lung injury/ARDS/acute interstitial pneumonia
|
diffuse, bilateral damage to alveolar capillary walls that usually starts in endothelium, or occasionally by direct injury to pneumocytes, and then the other is soon involved
inc. permeability allows for edema and fibrin exudate, which contributes to hyaline membrane endothelial damage triggers formation of microthrombi in capillaries inc. pro-inflammatory mediators especially NF-kappaB and dec. anti-inflammatory mediators; within 30 minutes, synthesis of IL8 in macrophages is increased which stimulates neutrophil activation and chemotaxis |
|
why are neutrophils important for the pathogenesis of ARDS?
|
increased activation and sequestration in lungs
release of tissue-damaging products maintain inflammatory cascade |
|
gross morphology of ARDS
|
heavy, firm, red, boggy, edematous
|
|
microscopic morphology of ARDS
|
early - congestion & edema, with inflammation and fibrin deposition; formation of hyaline membrane composed of fibrin, necrotic cell remnants, and edema fluid
late - type II pneumocyte hyperplasia (attempt to regenerate alveolar lining); granulation tissue in walls and alveolar spaces; usually resolves w/ min functional impairment |
|
what are the complications of unresolved ARDS?
|
1) intra-alveolar fibrosis
2) thickened alveolar septa (poor gas exchange) 3) proliferation of interstital cells and collagen deposition |
|
what are hyaline membranes composed of?
|
fibrin
necrotic cell remnants edema fluid |
|
clinical features of acute lung injury/ARDS?
|
pts are usually already seriously sick from the initiating problem
present with profound dyspnea and tachypnea, increasing cyanosis and hypoxia xray is initially normal, but eventually diffuse bilateral infiltrates form lungs become focally stiff with decrease in functional volume, causing a ventilation-perfusion mismatch with hypoxemia if fatal, usually b/c of sepsis or multi-organ failure |
|
acute interstitial pneumonia
|
usually occurs after 50 years old
clinically similar to ARDS, but no etiology is known; often starts with URI-like symptoms and progresses to ARDS-like symptoms in less than 3 weeks 1/3-3/4 die, most within 1-2 months; survivors get recurrence or develop chronic interstitial disease |
|
obstructive pulmonary diseases
|
increase in resistance to airflow, owing to partial or complete obstruction at any level (trachea to resp. bronchioles)
PFTs with limitation of max airflow rates during forced expiration **FEV1 is decreased** (1) emphysema (2) bronchitis (3) asthma (4) bronchiectasis |
|
restrictive pulmonary diseases
|
reduced expansion of lung parenchyma, with decreased total lung capacity
PFTs with reduced total lung capacity and normal/proportionately reduced expiratory flow rate **FEV1 is normal/reduced proportionately to lung capacity** (1) chest wall disorders (2) chronic interstitial diseases (3) chronic infiltrative diseases |
|
what is the major symptom of COPD?
|
dyspnea (difficulty breathing)
|
|
emphysema
|
abnormal, permanent enlargement of airspaces distal to the terminal bronchiole, accompanied by wall destruction without obvious fibrosis
strong association with heavy smoking 4 types: (1) centriacinar (centrilobular) (2) panacinar (panlobular) (3) paraseptal (distal acinar) (4) irregular emphysema **(3) and (4) are minor forms** |
|
centriacinar (centrilobular) emphysema
|
95% of emphysema
central (proximal) parts of acini, formed by resp. bronchioles are enlarged, but distal alveoli spared; if severe, distal acinus is secondarily involved normal and abnormal airspaces found in some acini walls of the affected spaces often have anthracotic pigmentation; bronchi and bronchioles are commonly surrounded by inflammation more common and more severe in the upper lobes, especially the apices pts are usually heavy smokers and often have concurrent chronic bronchitis |
|
what is the fourth leading cause of morbidity and mortality in the US?
|
emphysema
|
|
panacinar (panlobular) emphysema
|
acini uniformly enlarged from respiratory bronchiole to the alveoli (very large air spaces)
involves entire acinus, but not necessarily the entire lung affects lower zones and anterior margins; most severe at bases associated with alpha1-antitrypsin deficiency pt must stop smoking |
|
paraseptal (distal acinar) emphysema
|
proximal portion of acinus is normal, but the distal part is enlarged; multiple enlarged air spaces from 0.5 to 2 cm in diameter
adjacent to pleura, along the connective tissue septa, and at the margins of lobules; adjacent to areas of fibrosis or scarring more severe in upper half of lungs responsible for most spontaneous pneumothorax in young adults (sudden severe SOB in pts in 20s-30s) |
|
irregular emphysema
|
acinus irregularly involved (no set pattern of enlargement)
associated with scarring usually asymptomatic |
|
protease-antiprotease mechanism of emphysema pathogenesis
|
disturbance in balance of proteases (elastase) with antiprotease (alpha-1-antitrypsin) is helped by oxidant-antioxidant imbalance to cause alveolar wall damage
pts with homozygous alpha-1-antitrypsin deficiency develop emphysema, compounded by smoking |
|
what is the function of alpha-1-antitrypsin?
|
it is the major inhibitor of proteases, especially elastase
|
|
what is the normal phenotype for alpha-1-antitrypsin? what is the most common deficiency phenotype?
|
normal: PiMM (90% of the population)
deficiency: PiZZ (80% develop emphysema) |
|
what is the hypothesis to explain the aggravation of protease-antiprotease imbalance caused by smoking?
|
a) particles attract neutrophils and macrophages to alveoli
b) stimulate the release of elastase from neutrophils as well as enhancing elastase activity in macrophages c) oxygen free radicals contained in cigarette smoke inhibit alpha-1-antitrypsin and deplete antioxidants in the lung |
|
what types of elastase are inhibited by alpha-1-antitrypsin?
|
neutrophil elastase is inhibited
macrophage elastase is not inhibited |
|
why do smokers get centriacinar emphysema rather than other types?
|
smoke makes it to the small bronchi and bronchioles, attracting neutrophils and macrophages to these areas
|
|
why do patients with alpha-1-antitrypsin develop panacinar emphysema?
|
the enzyme is lacking throughout the acinus, which causes damage throughout
|
|
what is the effect of loss of elastic fibers in the walls of alveoli surrounding respiratory bronchioles in emphysema patients?
|
bronchiole collapse during expiration resulting in functional airflow obstruction (therefore an obstructive disease)
|
|
gross morphology of emphysema
|
upper 2/3 of lungs are more affected in centriacinar emphysema (most common form)
in panacinar emphysema, lungs are enlarged when inflated and can overlap/hide the heart in irregular emphysema, see large apical blebs or bullae secondary to scarring |
|
microscopic morphology of emphysema
|
with destruction of walls, get abnormally large alveoli causing grossly apparent blebs and bullae
club-shaped septa protrude into alveolar spaces respiratory bronchioles and vessels may be compressed may have fibrosis but not much inflammation may have bronchitis/bronchiolitis |
|
clinical features of emphysema
|
sits forward in hunched over position and pt is barrel chested with obvious prolonged expiration (expiratory phase > inspiratory phase)
pts not symptomatic until they lose 1/3 of functional lung capacity dyspnea becomes progressive with cough, wheezing (confused for asthma), severe weight loss (confused for CA) pink puffers - remain well oxygenated (pink) by overventilating (puffers) |
|
pink puffers vs. blue bloaters
|
pink puffers - pt overventilates and so they remain well oxygenated - primary pathology is emphysema
blue bloaters - pt is hypercapneic, hypoxemic, and cyanotic - primary pathology is chronic bronchitis |
|
what are the causes of death in COPD?
|
1) respiratory acidosis and coma
2) right sided heart failure 3) lung collapse from pneumothorax |
|
compensatory emphysema
|
hyperinflation of the lung with no destruction of septal walls/alveoli
removal of a lung or a portion of a lung causes hyperexpansion of the residual parenchyma to compensate |
|
senile emphysema
|
larger ducts with smaller alveoli
|
|
obstructive overinflation emphysema
|
lungs are expanded b/c air is trapped in by subtotal obstruction via a tumor or foreign body
a) ball-valving = air can get in but not out like a one-way valve b) complete obstruction of bronchus = air enters via pores of Kohn (collaterals bringing air in behind the obstruction) |
|
bullous emphysema
|
see large subpleural blebs or bullae
accentuation of one of the basic forms of emphysema creating subpleural cavities > 1cm can rupture, causing pneumothorax |
|
interstitial emphysema
|
entrance of air into the lung stroma, mediastinal connective tissue or subcutaneous tissue, rather than alveolar spaces
in most cases, alveolar tears in combination with cough and obstruction provide avenue for air to enter the stroma penetration wounds or fractured ribs can "cut" the lungs and allow air entry |
|
chronic bronchitis
|
clinical disease, not pathological, defined as a persistent cough with sputum production lasting for at least 3 months in at least two consecutive years
can be associated with emphysema (pts often have both) leads to cor pulmonale and heart failure; causes squamous metaplasia and dysplasia, leading to cancer mild/simple - no evidence of airflow obstruction chronic asthmatic bronchitis - intermittent bronchospasm and wheezing obstructive - some associated emphysema, especially in heavy smokers |
|
pathogenesis of chronic bronchitis
|
1) chronic irritation caused by inhaled substances/particles
2) neutrophils are attracted and secrete proteases 3) hypersecretion of mucus and hypertrophy of submucosal glands of trachea & bronchi 4) sputum overproduction causes productive cough infections have a secondary role, maintaining the bronchitis once it starts or producing exacerbations smoking is a paramount influence (90% occurs in smokers) |
|
gross morphology of chronic bronchitis
|
hyperemic, boggy, swollen mucosa
excess mucus or mucopurulent secretions and pus that can form casts (pull off bronchi and retain the shape) |
|
microscopic morphology of chronic bronchitis
|
increased mucus, chronic inflammation (with mostly lymphocytes)
increase in size of mucus secreting glands in trachea and bronchi (reid index is increased) increased # of goblet cells in small airways; may have squamous cell metaplasia or even dysplasia mucus plugging, inflammation, fibrosis in small airways causes bronchiolar narrowing in severe disease, see obliteration of lumens of bronchioles due to fibrosis (bronchiolitis obliterans) |
|
bronchiolitis obliterans
|
obliteration of lumens of bronchioles due to fibrosis, seen in severe chronic bronchitis
|
|
clinical features of chronic bronchitis
|
chronic productive cough, infections, cor pulmonale with heart failure
may develop emphysema blue bloaters - hypoxemia, mild cyanosis, hypercapnea |
|
bronchial asthma
|
chronic, relapsing, inflammatory disorder, characterized by hyperreactive airways leading to episodic reversible bronchoconstriction, owing to increased responsiveness of tracheobronchial tree to stimuli
Sx: severe dyspnea, coughing, wheezing, chest tightness; especially seen at night and early AM |
|
status asthmaticus
|
acute exacerbation of asthma that does not respond to standard treatments of bronchodilators and steroids
Sx: chest tightness, rapidly progressive dyspnea (shortness of breath), dry cough, use of accessory muscles, labored breathing and extreme wheezing life-threatening episode of airway obstruction considered a medical emergency complications: cardiac and/or respiratory arrest |
|
atopic asthma
|
most common type of bronchial asthma
classic type I HSN triggered by exposure to extrinsic allergen, which increases generation of IgE usually begins in childhood, commonly with a family history wheal and flare reaction is seen on skin test with the offending allergen inhaled antigen stimulates induction of type 2 helper T cells that release IL-4 and IL-5, which promote IgE production by B cells, growth of mast cells, and activation of eosinophils - subsequent exposure results in class I reaction |
|
what is the purpose of RAST tests?
|
look for IgE against a panel of allergens
**used for atopic asthma** |
|
non-atopic asthma
|
bronchial asthma initiated by non-immune mechanisms, commonly a viral respiratory tract infection (inhaled irritants may contribute)
probably caused by hyperirritability of the bronchial tree b/c inflammation caused by the infection lowers the threshold of vagal (bronchoconstricting) receptors to irritants |
|
drug induced asthma
|
uncommon bronchial asthma and hives caused by aspirin ingestion, triggered even by tiny doses
pt has recurrent rhinitis and nasal polyps aspirin inhibits COX pathway of arachidonic acid metabolism w/o affecting LOX, resulting in bronchoconstricting leukotriene release |
|
occupational asthma
|
bronchial asthma that develops after repeated exposure to fumes, dusts, gases, or chemicals; attacks can be triggered by minute quantities
combination of type I reaction, release of bronchoconstrictors, and hypersensitivity response |
|
pathogenesis of atopic asthma
|
inheritance of susceptibility genes making person prone to develop strong TH2 response to allergens
TH2 cells secrete interleukins that promote allergic inflammation and stimulate B cells to produce Abs, esp. IgE; the interleukins also recruit eosinophils and stimulate mucus production |
|
acute phase of atopic asthma
|
bronchoconstriction predominates within minutes of reexposure to allergens, which cause sensitized mast cells on mucosal surfaces
released mediators open intercellular tight junctions so that the antigen can get to the more numerous submucosal mast cells stimulation of subepithelial vagal receptors provokes bronchoconstriction, edema, and mucus secretion cytokines from mast cells attract other inflammatory cells, which cause the late phase response |
|
late phase of atopic asthma
|
inflammation predominates starting 4-8 hours after an initial attack and lasting 12-24 hours or longer
epithelial cells produce eotaxin, which recruits and activates eosinophils eosinophils release major basic protein which causes epithelial damage and airway constriction |
|
what mediators of atopic asthma respond to drug intervention?
|
LTC4, D4, E4
- all cause bronchoconstriction, increased vascular permeability, and increased mucus secretion ACh - causes smooth muscle constriction |
|
what mediators in atopic asthma are affected little/not at all with drug intervention?
|
histamine - causes bronchoconstriction
PgD2 - causes bronchoconstriction and vasodilation PAF - releases histamine and serotonin from platelets IL-1, IL-6, TNF, NO |
|
genetics of asthma
|
gene cluster on 5q - codes IL-3, 4, 5, 9, 13 and IL4R - involved in IgE regulation, as well as mast cell and eosinophil growth/differentiation
polymorphism of CD14 gene coding monocyte receptor for endotoxin ADAM-33 polymorphisms may accelerate proliferation of bronchial smooth muscle and fibroblasts leading to bronchial hyperplasia and fibrosis beta2 adrenergic receptor variations associated with differential airway hyperresponsiveness acidic mammalian chitinase upregulation (YKL-40) correlates with severity of asthma |
|
polymorphisms in IL13 gene have strong, consistent association with what?
|
allergies and asthma
|
|
gross morphology of bronchial asthma
|
overdistended lungs caused by overinflation
occlusion of bronchi and bronchioles by thick mucous plugs |
|
microscopic morphology of bronchial asthma
|
- mucous plugs with whorls of shed epithelium (Curschmann spiral)
- eosinophils and Charcot-Leyden crystals of an eosinophil membrane protein - thickened basement membrane and sub-membrane fibrosis - edema & inflammation of bronchial wall (eosinophils constitute 5-50%) - increased size of submucosal glands in glandular layer - bronchial muscle wall hypertrophy |
|
clinical features of bronchial asthma
|
an attack can last for hours and can be followed by prolonged cough as the pt starts bringing up the secretions
if severe, can eventually lead to emphysema, bronchiectasis, cor pulmonale, and heart failure superimposed infections can lead to chronic bronchitis, bronchiectasis, and pneumonia |
|
what is a Curschmann spiral?
|
mucous plugs with whorls of shed epithelium seen in bronchial asthma
|
|
what are Charcot-Leyden crystals?
|
crystals of an eosinophil membrane protein that are formed after its excretion
seen in patients with bronchial asthma |
|
bronchiectasis
|
permanent dilation of bronchi and bronchioles caused by destruction of muscle and elastic tissue, resulting from or associated with chronic necrotizing infections
with better antibiotic control of infections, is now uncommon |
|
causes of bronchiectasis
|
1) bronchial obstruction (disease is localized to the obstructed segment with tumor or foreign body; diffuse disease with asthma or chronic bronchitis)
2) congenital/hereditary (defect in bronchial development, sequestration, cystic fibrosis, immunodeficiencies, or Kartagener syndrome) 3) necrotizing pneumonias (S. aureus, H. influenzae, P. aeruginosa, TB, viruses, Aspergillus) |
|
what is the most common cause of bronchiectasis?
|
cystic fibrosis
|
|
what is Kartagener syndrome?
|
aka primary ciliary dyskinesia
rare, ciliopathic, autosomal recessive genetic disorder that causes a defect in the action of the cilia lining the respiratory tract (lower and upper, sinuses, Eustachian tube, middle ear) and fallopian tube, and also of the flagella of sperm in males main consequence of impaired ciliary function is reduced or absent mucus clearance from the lungs, and susceptibility to chronic recurrent respiratory infections, including sinusitis, bronchitis, pneumonia, and otitis media causes bronchiectasis with progressive damage to the resp. system |
|
general pathogenesis of bronchiectasis
|
combination of obstruction and infection
obstruction interferes with normal clearing mechanisms and causes accumulation of secretions; if obstruction persists, especially in periods of growth, causes abnormal development of lungs infection causes inflammation, necrosis, fibrosis, and dilation of airways |
|
pathogenesis of bronchiectasis caused by cystic fibrosis
|
defective mucociliary action and accumulation of thick secretions cause obstruction which predisposes to infection
repeated infections damage walls, muscle, and elastic fibers small bronchioles become obliterated by fibrosis |
|
primary ciliary dyskinesia
|
AR disorder with variable penetrance that causes the absence or shortening of dynein arms that are responsible for coordinated beating of cilia so that the cilia beat in many directions rather than just one direction
poorly functioning cilia leads to retention of secretions which then leads to recurrent infections males are infertile due to the ineffective mobility of sperm tails called Kartagener syndrome if the pt has bronchiectasis, sinusitis, and situs inversus - present in half of pts with primary ciliary dyskinesia |
|
pathogenesis of bronchiectasis caused by allergic bronchopulmonary aspergillosis
|
pt has hypersensitivity to aspergillus
complication of asthma/cystic fibrosis severe inflammation with lots of eosinophils mucus plugs cause the obstruction which interferes with normal clearing mechanisms and leads to the accumulation of secretions |
|
gross morphology of bronchiectasis
|
usually bilateral lower lobe involvement that is more severe in distal bronchi/bronchioles
if caused by a local process, there is sharp, segmental lung involvement dilated airways (up to 4x normal) - cylindroid = long, tube-like - fusiform - saccular airways can follow the airway out to the pleural surface (normally they stop 2-3cm from the pleura) cut surface - cysts filled with mucoid or mucopurulent material |
|
microscopic morphology of bronchiectasis
|
acute/chronic inflammation within the wall
desquamation of lining epithelium and ulceration of the alveolar wall pseudostratification of columnar epithelium, or squamous metaplasia of remaining epithelium can have abscess formation along with bronchiectasis with time, see fibrosis of bronchial/bronchiolar wall |
|
clinical features of bronchiectasis
|
(1) severe and persistent cough
- tends to be paroxysmal, especially on rising in the AM - postural change (sitting up) causes drainage of pus into the bronchi (2) copious amounts of foul-smelling purulent sputum (3) fever if infection is present (4) mixed organisms are cultured |
|
general facts about diffuse (restrictive) interstitial diseases
|
heterogeneous group, characterized by diffuse chronic lung involvement of pulmonary connective tissue, especially interstitium of alveolar walls
cause dyspnea, tachypnea, and eventual cyanosis, but no wheezing Xray shows diffuse infiltration by small nodules, irregular lines, or ground glass shadows eventually causes secondary pulmonary hypertension and right-sided heart failure in advanced disease, see honeycomb lung; it is hard to tell the cause at this point |
|
idiopathic pulmonary fibrosis
|
aka cryptogenic fibrosing alveolitis
aka chronic interstitial pneumonitis aka usual interstitial pneumonitis restrictive pulmonary disease |
|
pathogenesis of idiopathic pulmonary fibrosis
|
repeated cycles of epithelial activation/injury by an unidentified agent
inflammation is thought to be mainly TH2 mediated (eosinophils, mast cells, IL-3, IL-4) TGF-beta1 is released from injured epithelial cells and generally promotes fibrosis abnormal epithelial repair causes excess fibroblast/myofibroblast proliferation, leading to more fibrosis |
|
familial pulmonary fibrosis
|
mutations that shorten telomeres cause rapid senescence and increased apoptosis of alveolar epithelial cells
TGF-beta1 negatively regulates telomerase activity, which facilitates apoptosis and the death/repair cycle TGF-beta1 also regulates caveolin-1, which is an inhibitor of fibrosis |
|
gross morphology of idiopathic pulmonary fibrosis
|
cobblestoned pleural surfaces from scar retraction
cut-surface: firm rubbery white areas from fibrosis - lower lobe predominates - subpleural and along interlobular septa |
|
microscopic morphology of idiopathic pulmonary fibrosis
|
patchy interstitial fibrosis; cystic spaces are lined by hyperplastic type II pneumocytes or bronchial epithelium (honeycomb fibrosis)
early - exuberant fibroblastic proliferation later - fewer cells with more collagen deposition very typical is coexistence of early and late lesions (this isn't seen in other fibrotic diseases) mild to moderate inflammation in fibrotic areas |
|
clinical features of idiopathic pulmonary fibrosis
|
most commonly appears in pts between 40 and 70 years old - presents as gradual increase of dyspnea on exertion with a dry, non-productive cough
late hypoxemia, cyanosis, clubbing unpredictable course, usually with gradual deterioration of lung function, despite treatment some run an acute course, getting worse very rapidly mean survival is three years (pt needs a lung transplant) |
|
nonspecific interstitial pneumonia
|
restrictive disease
usually presents between 46 and 55 years old wastebasket diagnosis with much better prognosis than usual interstitial pneumonia 2 patterns: (1) cellular pattern - mild-moderate chronic interstitial inflammation - can have patchy or uniform distribution (better px) (2) fibrosing pattern - diffuse or patchy interstitial fibrosis w/ all lesions of same age Sx: dyspnea and cough for several months |
|
cryptogenic organizing pneumonia (COP)
|
aka bronchiolitis obliterans with organizing pneumonia (BOOP)
Sx: cough, dyspnea subpleural or peribronchial patchy areas of consolidation (loose plugs of organizing connective tissue in alveolar ducts, alveoli, bronchioles) that are all the same stage underlying architecture is normal occasionally there is spontaneous recovery, but usually pts need steroids for at least 6 months |
|
lung and collagen vascular disease
|
various patterns of interstitial pneumonias
scleroderma usually non-specific interstitial pneumonia pattern SLE - can have transient patchy lung infiltrates that disappear and reappear RA - lung involvement is fairly common - chronic pleuritis - diffuse interstitial pneumonia and fibrosis - rheumatoid nodules in lung, common in subQ tissue - pulmonary HTN - 30-40% of RA pts have abnormal PFTs |
|
pneumoconioses
|
reaction of lungs to inhalation of mineral dusts in the workplace (anthracosis, silicosis, asbestosis, etc.) or organic or inorganic particulates or chemical fumes or vapors
|
|
on what does development of pneumoconiosis depend?
|
1) amount of dust retained in lung ([dust] in ambient air, duration of exposure, effectiveness of clearance, depressed mucociliary clearance)
2) size of particles (1-5um reaches small airways and air sacs and settle into linings) 3) particle solubility and reactivity 4) additional effects of other irritants |
|
particle solubility and reactivity
|
smaller particles have larger surface area-to-mass ratio and are more likely to cause acute lung injury
larger particles resist dissolution and can persist for years in parenchyma, evoking fibrosing pneumoconioses quartz particles can cause direct tissue injury via free radicals and can trigger macrophages to release inflammatory and fibroblastic mediators |
|
coal workers' pneumoconiosis (CWP)
|
reaction of lungs to inhaled coal
can be asymptomatic anthracosis w/o perceptible cell reaction, or a simple CWP w/ little lung dysfunction, or complicated/progressive massive fibrosis (PMF) <10% of simple CWP progresses to PMF |
|
progressive massive fibrosis (PMF)
|
generic term for confluent, fibrosing reaction in the lung that can be a complication of any of the pneumoconioses
most common in coal workers' pneumoconiosis and in silicosis |
|
anthracosis
|
carbon ingested by macrophages accumulates in connective tissue along lymphatics and in hilar lymph nodes
gross morphology, see linear streaks and black nodes seen in coal workers, urban dwellers, and smokers |
|
simple coal workers' pneumoconiosis
|
1-2mm coal macules (of carbon-laden macrophages and small amounts of collagen) and larger nodules that can be confluent
most lesions are adjacent to respiratory bronchioles where the coal dust accumulates the upper lobes and upper parts of the lower lobes are more affected can progress to complicated CWP |
|
complicated coal workers' pneumoconiosis
|
progresses from simple coal workers' pneumoconiosis (in <10% of cases nowadays)
takes years of exposure, but stopping exposure doesn't help at this point multiple black scars 2-10cm Sx: lung dysfunction, pulmonary HTN, cor pulmonale microscopic: dense collagen and pigment often with a necrotic center of central ischemia |
|
for what diseases are pts with coal exposure at increased risk?
|
chronic bronchitis
emphysema |
|
silicosis
|
reaction of lungs to inhaled crystalline silicon dioxide (silica)
most prevalent of chronic occupational diseases worldwide need decades of exposure - sandblasters and mineworkers; less commonly, months to years of exposure can cause acute silicosis |
|
pathogenesis of chronic silicosis
|
crystalline forms (e.g. quartz) are much more fibrogenic than amorphous forms
macrophages that ingest silica release mediators (TNF, O2 derived free radicals, IL-1, fibrogenic cytokines, fibronectin, lipid mediators) before they die b/c silica is toxic to macrophages reduced fibrogenic effect if mixed with other minerals and quartz; in workplace is rarely pure so is less dangerous |
|
gross morphology of chronic silicosis
|
early lesions in upper lung zones
tiny, just palpable nodules that are pale to black (if mixed with coal) and coalesce into hard, fibrotic scars that can have some central softening and cavitation due to superimposed TB/ischemia can get fibrotic lesions in nodes or pleura nodes can get eggshell calcification late in course, progresses to progressive massive fibrosis (PMF) |
|
microscopic morphology of chronic silicosis
|
nodular lesions consisting of concentric layers of hyalinized collagen with capsule of even more condensed collagen
birefringent silica revealed by polarized microscopy |
|
clinical features of silicosis
|
usually pick up as an Xray finding (fine nodularity in early stages) in asymptomatic pts
- pulmonary function tests are normal or only moderately abnormal don't become dyspneic until progressive massive fibrosis (PMF), at which point stopping exposure usually doesn't help increased susceptibility to TB controversial cancer association |
|
asbestosis
|
lung reaction to inhalation of asbestos
2 forms: (1) serpentine - curly, flexible fibers (2) amphibole - straight, stiff, brittle fibers - more pathogenic initial injury at bifurcation of small airways and ducts where fibers land and penetrate; macrophages try to ingest and clear, but then release chemotactic and fibrogenic mediators eventually generalized inflammation and interstitial fibrosis is diffuse rather than the nodular pattern in silicosis asbestos is both a tumor promoter and initiator |
|
forms of asbestosis
|
1) serpentine - curly, flexible fibers
- most of industrial asbestos - more apt to be trapped and removed in URT - more soluble, so eventually leached from tissue 2) amphibole - straight, stiff, brittle fibers - more pathogenic, esp regarding mesothelioma - can get into deep lung, penetrate epithelium, and reach interstitium |
|
asbestos as a tumor promoter and initiator
|
synergistic with other carcinogens
asbestos exposure alone increases risk of bronchogenic CA 5x more than non-smoking population |
|
gross morphology of asbestosis
|
diffuse interstitial fibrosis that starts in lower lobes and subpleura and then progresses to middle and upper lobes
see a thick visceral pleura pleural fibrous plaques are the most common manifestations of asbestos exposure - well circumscribed, dense collagen - often have calcium - located on anterior and posterolateral parietal pleura as well as on the diaphragm - no asbestos bodies uncommonly induce pleural effusions |
|
manifestations of asbestosis
|
pleural effusions (uncommon)
bronchogenic CA mesothelioma |
|
what is mesothelioma?
|
a rare tumor of the lungs with 1000x greater risk in populations exposed to asbestos
smoking is not contributory |
|
microscopic morphology of asbestosis
|
asbestos bodies - gold-brown, fusiform or beaded rods with translucent centers
- asbestos fiber coated with Fe-containing proteinaceous material fibrosis starts around resp. bronchioles and alveolar ducts, extends into sacs and spaces and causes enlarged air spaces with thick fibrous walls end result is honeycomb lung |
|
what are asbestos bodies?
|
gold-brown, fusiform or beaded rods with translucent centers
consist of asbestos fiber coated with Fe-containing proteinaceous material Fe is derived from ferritin of macrophages trying to phagocytose asbestos fiber ferruginous bodies are similar - Fe-coatedparticles, but with no distinctive core |
|
clinical features of asbestosis
|
starts with exertional dyspnea with a productive cough which then progresses
rare before 10 years after first asbestos exposure; more commonly presents at 20 years or more after first asbestos exposure can be static or progressive to CHF, cor pulmonale pleural plaques are asymptomatic |
|
what chemotherapy drug is directly toxic to the lungs?
|
bleomycin
|
|
what pulmonary side effect is associated with amiodarone?
|
pneumonitis (5-15% of pts)
|
|
pulmonary complications of radiotherapy
|
radiation pneumonitis, mostly to lung with radiation port
acute disease in 10-20% of pts 1-6 months after therapy - fever, dyspnea, effusion, infiltrates - may respond to steroids or progress to chronic disease chronic disease - fibrosis - looks like diffuse alveolar damage - severe epithelial atypia - foam cells in vessel walls |
|
sarcoidosis
|
systemic disease with unknown cause
causes noncaseating granulomas in many organs; causes lung involvement and/or hilar adenopathy in 90% diagnosis of exclusion (must rule out TB, fungal infections, beryllosis) more prevalent in women, 10x more common in blacks than whites, more prevalent in SE US |
|
pathogenesis of sarcoidosis
|
disordered immune regulation in a genetically predisposed pt who is exposed to unknown environmental agents
local immune abnormalities around granuloma (inc. CD4 T cells, inc. levels of TH1-derived cytokines, inc. levels of TNF) systemic immune abnormalities: anergy to common skin test Ags, polyclonal hypergammaglobulinemia genetic: association with HLA-A1 & HLA-B8 environmental: mycobacteria, rickettsia, propionibacterium acnes |
|
what kind of T cell population is found in sarcoidotic granulomas?
|
oligoclonal CD4 T cell proliferation, rather than polyclonal
|
|
what manifestation of hyper T-cell dysregulation is common in sarcoidosis patients?
|
polyclonal hypergammaglobulinemia
|
|
microscopic morphology of sarcoidosis
|
non-caseating granulomas composed of tightly clustered epitheloid cells
langhans cells (horseshoe nuclei) or foreign body type giant cells may be replaced by hyalinized scars laminated concretions - Schaumann bodies Stellate inclusions - ateroid bodies within giant cells |
|
effects of sarcoidosis on the lungs
|
microscopic disease or coalesced granulomas up to 2cm usually located along the lymphatics around bronchi and vessels
often see multiple lesions in varying stages of development lesions heal with fibrosis and hyalinization in time CD4/CD8 ratio > 2.5 |
|
effects of sarcoidosis on the lymph nodes
|
lymphadenopathy of hilar and mediastinal lymph nodes, but can involve others
nodes can be calcified tonsils are involved in 1/4-1/3 of pts |
|
effects of sarcoidosis on the spleen and liver
|
microscopic disease in 75%
gross splenomegaly in 20% liver affected less often - usually scattered granulomas in the portal triads rather than parenchyma |
|
effects of sarcoidosis on bone marrow
|
affects bone marrow in 20% of pts
particular affinity for phalanges causes small areas of resorption within marrow cavity or a diffuse reticulated pattern throughout the cavity |
|
effects of sarcoidosis on the skin
|
30-50% of pts
varying appearance: - nodules - plaques - lupus type |
|
effects of sarcoidosis on the eye, lacrimal glands, and salivary glands
|
affects 20-50% of pts
can cause glaucoma or blindness if eye is involved, the lacrimal gland is often inflamed and producing a decreased amount of tears if bilateral salivary glands are affected, can cause Mikulicz syndrome |
|
effects of sarcoidosis on muscle
|
weakness, tenderness, aching, fatigue
|
|
clinical features of sarcoidosis
|
protean/variable manifestations
resp. Sx: SOB, cough, hemoptysis systemic Sx: fever, fatigue, wt loss, night sweats unpredictable course (progressive, relapsing/remitting, or permanent remission occasionally by steroids or spontaneous) 70% recover or have min manifestations 20% have some permanent loss of lung or visual fcn 10% die of progressive pulmonary fibrosis or other organ damage less amount of disease at time of dx, the better the prognosis |
|
hypersensitivity pneumonitis
|
immunologically mediated, predominantly interstitial disorder with alveolar involvement caused by prolonged exposure to inhaled organic dusts or other occupational antigens
early removal of agent prevents progression to chronic fibrotic disease early lesions are type III and later granulomas are type IV hypersensitivity reactions Examples: farmer's lung, pigeon breeder's lung, humidifier/air conditioner lung |
|
farmer's lung
|
type of hypersensitivity pneumonitis caused by actinomycetes in humid warm hay
|
|
pigeon breeder's lung
|
type of hypersensitivity pneumonitis caused by inhalation of antigens from the serum, excretions, or feathers of birds
|
|
humidifier/air conditioner lung
|
type of hypersensitivity pneumonitis caused by a thermophilic bacteria
|
|
immunologic abnormalities seen in hypersensitivity pneumonitis
|
acute phase - inc. of proinflammatory chemokines IL8 and MIP1alpha
inc in numbers of CD4 T cells and CD8 T cells most pts have specific Abs to the causative agent in serum, suggestive of a type III hypersensitivity complement & Igs within vessel walls |
|
microscopic morphology of hypersensitivity pneumonitis
|
interstitial pneumonitis (lymphocytes, plasma cells, and macrophages)
noncaseating granuloma intraalveolar infiltrate late - interstitial fibrosis and obliterative bronchiolitis |
|
clinical features of hypersensitivity pneumonitis
|
acute - recurring attacks of fever, dyspnea, cough, elevated wbcs
- diffuse & nodular Xray infiltrates - restrictive PFT pattern - usually occurs 4-6 hours post-exposure chronic - no acute exacerbations, but progressive resp. failure - looks like other restrictive diseases |
|
what are the five categories of restrictive pulmonary diseases?
|
(1) fibrosing diseases
(2) granulomatous disease (3) pulmonary eosinophilia (4) smoking-related interstitial diseases (5) pulmonary alveolar proteinosis |
|
acute eosinophilic pneumonia with respiratory failure
|
rapid onset of fever, dyspnea, and hypoxia; Xray shows diffuse infiltrates
unknown cause fluid from a bronchioalveolar lavage is > 25% eosinophils responds quickly to steroids |
|
simple pulmonary eosinophilia
|
benign transient lung lesions with accompanying eosinophilia in the blood
Xray shows irregular densities lung septae are thickened by eosinophils and occasional giant cells no vasculitis, fibrosis, or necrosis |
|
chronic eosinophilic pneumonia
|
aggregates of lymphocytes and eosinophils in septal walls and alveolar spaces mostly in peripheral lung
pt presents with fever, night sweats, and dyspnea responds to steroids diagnose after excluding other entities |
|
desquamative interstitial pneumonitis
|
aggregates of macrophages in alveoli (not desquamated epithelial cells)
slow development of cough, dyspnea, and eventually severe respiratory embarassment (distress/failure) Xray shows ground glass infiltrate in BOTH lower lobes caused by pneumocytic hyperplasia |
|
microscopic morphology of desquamative interstitial pneumonitis
|
large numbers of macrophages with abundant cytoplasm and brown pigment (smokers' macrophages), some with finely granular iron and others with lamellated surfactant bodies
septae are thickened by sparse mononuclear inflammation hyperplasia of epithelial cells (pneumocytes) no interstitial fibrosis or mild at worst |
|
clinical features of desquamative interstitial pneumonitis
|
pts present in the 4th-5th decade as dyspnea and a dry cough developing over wks to mos, as well as clubbing of digits
PFTs show mild restriction ALL pts are cigarette smokers and most are males (2:1) responds to steroids (and if pt concurrently stops smoking, response is 100%) |
|
respiratory bronchiolitis-associated interstitial lung disease
|
pt presents with mild dyspnea and cough, as well as a hx of smoking >30 pack-years
pigmented intraalveolar macrophages are found in the 1st-2nd order respiratory bronchioles and aggregates of smokers' macrophages in respiratory bronchioles, alveolar ducts, and peribronchiolar spaces patchy submucosal and peribronchiolar chronic inflammation/infiltrates with mild peribronchiolar fibrosis pt may have mild centrilobular emphysema quitting smoking improves condition but findings are similar btwn smokers & non-smokers |
|
pulmonary alveolar proteinosis
|
rare pulmonary restrictive disease caused by abnormal accumulation of surfactant within the alveoli, interfering with gas exchange
Xray: patchy asymmetric opacification Histo: accumulation of a-cellular surfactant |
|
acquired pulmonary alveolar proteinosis
|
anti-GM-CSF antibody impairs surfactant clearance by alveolar macrophages
recurs in patients, even with lung transplants, because antibody is produced systemically accounts for 90% of cases of PAP |
|
congenital pulmonary alveolar proteinosis
|
presents as immediate onset of neonatal respiratory distress; is rapidly progressive and fatal if pt doesn't get a transplant by 3-6 months
associated gene mutations: - ATP-binding cassette A3 (ABCA3) - most common - surfactant proteins B & C - GM-CSF & GM receptor beta chain - GM receptor |
|
secondary pulmonary alveolar proteinosis
|
VERY uncommon restrictive pulmonary disease
presents in patients with inhalational syndromes, including acute silicosis, as well as in patients with immunodeficiencies, malignancies, hematopoietic disorders, or lysinuric protein intolerance |
|
morphology of pulmonary alveolar proteinosis
|
gross - marked increase in size and weight of lung, with turbid fluid exuding from involved areas
micro - accumulation of homogeneous, dense, granular material with lipid and cholesterol clefts, as well as PAS-positive material in alveolar spaces - confluent consolidation of large areas, with no inflammation - involved alveoli have hyperplastic pneumocytes and focal areas of necrosis |
|
clinical features of pulmonary alveolar proteinosis
|
cough (may produce chunks of gelatinous material)
ranges from benign with eventual resolution to resp. insufficiency pts are at risk for infections treat with whole lung lavage and 50% respond to GM-CSF administration |
|
pulmonary embolism (PE)
|
occlusion of large pulmonary arteries is nearly always caused by a thromboembolism (95% originate in deep veins of the legs)
responsible for >50,000 deaths/year and is the sole or major contributor in 10% of acute hospital deaths |
|
pathogenesis of pulmonary embolism (PE)
|
pt almost always has an underlying disorder or is ill or has a hypercoagulable state
primary - thrombus builds up in veins via coagulation cascade secondary - recent surgery, central lines, pregnancy or BCP, cancer, or obesity |
|
morphologic changes caused by a large saddle embolus in the pulmonary artery (or major branches)
|
often associated with acute cor pulmonale and no other changes because the patient often dies very quickly
|
|
gross morphology of small
|
smaller emboli travel further through the pulmonary artery system into more peripheral vessels
- no infarction if there is adequate bronchial arterial circulation - infarction results if bronchial system circulation is inadequate (i.e. pts with heart/lung disease) infarction occurs with about 10% of emboli; can be multiple lesions of variable size, most of the time located in the lower lobes - infarct is triangular with the apex pointing toward the hilum and extending to the lung periphery (occluded vessel is near the apex); it eventually shrinks and is replaced by a grey-white scar - if hemorrhagic, appears as a raised red-blue area - adjacent pleura often has fibrinous exudate |
|
what important feature distinguishes a pre-mortem clot (PE) from a post-mortem clot?
|
lines of Zahn are found in pre-mortem clots, but not in post-mortem clots
|
|
microscopic morphology of PE
|
thromboembolus found in vessel
if there is an infarct, see ischemic necrosis in an area of hemorrhage if the embolus was infected, the infarcted area will have intense inflammation (septic infarct) and may form an abscess |
|
clinical features of PE
|
large embolus can cause instantaneous death
- during CPR, may restore rhythm on EKG, but not pulses b/c of massive circulatory block smaller embolus in a normal person presents as transient chest pain, cough if there's hemorrhage w/o infarct and presents as chest pain, cough, hemoptysis, dyspnea, tachypnea, and fever (possibly with pleuritis and friction rub) if PE causes infarct after first embolus, there is about a 30% chance of developing a second embolus |
|
what are the complications of multiple small pulmonary emboli?
|
long-term pulmonary HTN
chronic cor pulmonale |
|
clinical Dx of PE
|
Xray: wedge-shaped infiltrate at 12-36 hours if PE causes infarct
lung scan: ventilation/perfusion discrepancy; abnormality on angiography D-dimer testing: elevated |
|
Tx for PE
|
prevention: mechanical (early ambulation post surgery), anticoagulation if pt is high risk, vena caval filters
Tx of established emboli: anticoagulation (heparin, etc.), and thrombolysis in some |
|
in what patients do you see in situ pulmonary thrombosis?
|
in situ thrombosis is rare, but is seen in pts with pulmonary HTN, pulmonary atherosclerosis, and heart failure
|
|
pulmonary hypertension
|
normal pulmonary pressure = 1/8 of systemic
considered pulmonary HTN when pressure = 1/4 of systemic primary is idiopathic, is uncommon, and is usually sporadic (though 5% is familial with incomplete penetrance) secondary is more common and has several causes |
|
causes of secondary pulmonary hypertension
|
(1) chronic obstructive or interstitial lung diseases (inc. pulmonary arterial resistance)
(2) congenital/acquired heart disease (mitral valve stenosis) (3) recurrent thromboemboli (dec. in functional x-sectional area of pulmonary vascular beds with inc. in pulmonary vascular resistance) (4) autoimmune diseases involving pulmonary vasculature (5) obstructive sleep apnea associated with obesity (6) bush tea (contains crotalaria spectabilis, a plant in the tropics) (7) prescription appetite depressant drugs (aminorex) (8) prescription antiobesity drugs (fenfluramine & phentermine or fen-phen) |
|
pathogenesis of primary familial pulmonary hypertension
|
caused by mutations in bone morphogenic protein receptor type 2 (BMPR2)
without BMP-BMPR2 signalling in vascular smooth muscle, have muscle proliferation loss of a single allele causes disease state (dominant negative; loss of second allele may occur in vascular wall), but only in 25-50% of pts (incomplete penetrance b/c of modifier genes and/or environmental triggers |
|
what is BMPR2?
|
bone morphogenic protein receptor type 2
a member of the TGF-beta receptor superfamily that binds TGF-beta and bone morphogenic peptide (BMP) BMP-BMPR2 signalling is important in embryogenesis, apoptosis, cell proliferation, and cell differentiation (effects depend on environment; in vascular smooth muscle, favors apoptosis) mutated in 50% of primary familial pulmonary hypertension and in 25% of primary sporadic pulmonary hypertension |
|
pathogenesis of secondary pulmonary hypertension
|
dysfunction of endothelial cells results in release of products promoting vasoconstriction or causing platelet activation/adhesion (growth factor & cytokine release can induce migration/proliferation of smooth muscle)
in pts with a spastic component, vascular resistance can be decreased with vasodilators |
|
gross morphology of pulmonary hypertension
|
many organizing or recanalized thrombi in PE
coexistence of emphysema, diffuse fibrosis, and/or chronic bronchitis implicates hypoxia as the cause right ventricular hypertrophy |
|
microscopic morphology of pulmonary hypertension
|
atheromatous deposits in large vessels
medial hypertrophy of muscular and elastic arteries at any level, but most prominent in small arteries and arterioles - medial muscular hypertrophy - intimal fibrosis - pinpoint lumen - best developed in primary disease pts with primary pulmonary hypertension can develop plexogenic pulmonary arteriopathy - capillary tufts spanning the lumen of a dilated, thin-walled artery |
|
plexogenic pulmonary arteriopathy
|
capillary tufts spanning the lumen of a dilated, thin-walled artery
present in: (1) primary pulmonary hypertension (2) congenital heart disease with L-R shunt (3) drugs (4) HIV |
|
clinical features of pulmonary hypertension
|
signs/symptoms only present with advanced disease
primary is most common in females btwn 20-40 (presents as dyspnea and fatigue with occasional anginal-type pain) progresses to respiratory distress, cyanosis, and right ventricular hypertrophy death occurs in 2-5 years in 80% of pts from decompensated cor pulmonale often with pneumonia and thromboemboli |
|
goodpasture syndrome
|
simultaneous proliferative glomerulonephritis and necrotizing hemorrhagic intersitial pneumonia
usually presents in males in their teens-20s usually begins with hemoptysis and consolidations on Xray and then progresses to renal disease which may cause rapid renal failure uremia is the usual cause of death |
|
pathogenesis of goodpasture syndrome
|
antibodies are formed against the noncollagenous domain of alpha-3 chain of collagen IV
antibodies cause inflammatory destruction in glomerular and pulmonary basement membranes trigger is unknown, but involved epitopes are normally hidden, so environmental triggers (viral infections, hydrocarbon solvent, cigarette smoke) must expose them associated with HLA subtypes |
|
effects of goodpasture syndrome on lungs
|
necrotizing hemorrhagic interstitial pneumonia
heavy lungs with areas of red-brown consolidation - focal acute necrosis of alveolar walls - intra-alveolar hemorrhage (with organization and hemosiderin-laden macrophages) - pneumocyte hyperplasia - fibrous thickening of septa on immunofluorescence see linear deposits of Ig along basement membranes of septal walls |
|
effects of goodpasture syndrome on kidneys
|
proliferative glomerulonephritis
- in early cases, focal proliferative glomerulonephritis - in rapidly progressing glomerulonephritis, see crescentic glomerulonephritis linear immunofluorescence for Ig and complement |
|
clinical features of goodpasture syndrome
|
simultaneous proliferative glomerulonephritis (kidney problems) and necrotizing hemorrhagic interstitial pneumonia (lung problems)
seen in males in teens to 20s Sx: hemoptysis and renal failure Xray: consolidations treat with plasma exchange to remove Abs and chemical mediators from circulation or with immunosuppression |
|
idiopathic pulmonary hemosiderosis
|
insidious onset of productive cough, hemoptysis, anemia, and weight loss
intermittent, diffuse alveolar hemorrhage with diffuse infiltrate similar to Goodpasture Syndrome, but seen in younger adults and children cause is unknown responds to long term steroids/immunosuppression some pts develop other autoimmune problems in the long term |
|
morphology of idiopathic pulmonary hemosiderosis
|
gross - moderate increase in weight of lung with areas of red to red-brown consolidation
microscopic - varying hemorrhae and hemosiderosis in septa and in macrophages in alveolar spaces - hyperplasia of type 2 pneumocytes - varying interstitial fibrosis - no inflammation (no anti-basement membrane antibodies detected) |
|
wegener granulomatosis
|
autoimmune disease involving upper respiratory tract and lung, as well as other organs
Sx: hemoptysis capillaritis and scattered, poorly formed granulomas (granulomas are well formed in sarcoidosis) sometimes lung is the only available tissue for biopsy |
|
what are the nasal defense mechanisms against infections? how are they impaired?
|
sneezing and blowing
protects from larger particles (>10um in diameter) impaired by lack of cough reflex (can be caused by coma, drugs, and chest pain) |
|
what are the tracheobronchial defense mechanisms against infections? how are they impaired?
|
mucociliary action
protects from particles 3-10um in diameter impaired by impaired ciliary function (caused by cigarette smoke or genetic defect) or destruction of epithelium (caused by viral disease) |
|
what are the alveolar defense mechanisms against infections? how are they impaired?
|
macrophages
protects from particles 1-5um in diameter impaired by EtOH, smoking, anoxia, too much O2, congestion/edema, accumulation of secretions (cystic fibrosis & bronchial obstruction), and atelectasis |
|
what causes most pneumonias?
|
inhalation of organisms
minority are secondary seeding from another site of infection |
|
what are the predisposing factors for community-acquired pneumonia?
|
extremes of age (very young or very old) and other immunocompromised pts
lack/loss of spleen chronic diseases |
|
streptococcus pneumoniae (pneumococcus)
|
most common cause of community-acquired pneumonia
gram-pos diplococci more penicillin resistant strains cause pneumonia important to give vaccines to pts at high risk |
|
what is the most common cause of community-acquired pneumonia?
|
streptococcus pneumoniae (pneumococcus)
|
|
haemophilus influenzae
|
gram-neg bacillus that commonly colonizes the URT
causes life-threatening pneumonias (high mortality) and meningitis in young children; causes community-acquired acute pneumonia in adults (common infection; not as severe) most common bacterial cause of acute exacerbation of COPD smaller bronchi are involved in pneumonia - plugged by fibrinopurulent exudate - pneumonia is usually lobular and patchy (occasionally lobar) |
|
what is clinically important about the encapsulated vs. non-encapsulated forms of H. influenzae?
|
encapsulated form dominates unencapsulated by secreting haemocin, which kills the unencapsulated form
with vaccines, infections with the unencapsulated forms (otitis media, sinusitis, bronchopneumonia) are increased survival in bloodstream correlates with presence of capsule (prevents opsonization & phagocytosis) |
|
what is the most common bacterial cause of acute exacerbation of COPD?
|
Haemophilus influenzae
2nd most common is Moraxella catarrhalis |
|
Moraxella catarrhalis
|
gram-negative diplococcus
causes pneumonia, especially in the elderly, and causes otitis media in children second most common bacterial cause of acute exacerbation of COPD |
|
Staphylococcus aureus (pulmonary)
|
gram-pos cocci arranged in a cluster of grapes
often causes a secondary pneumonia following a viral respiratory illness causes pneumonia (and bacterial endocarditis) in IV drug abusers high incidence of complications (abscess, empyema) |
|
Klebsiella pneumoniae
|
gram-neg bacillus
most frequent cause of gram-neg bacterial pneumonia common in debilitated, malnourished pts (i.e. chronic alcoholics) characteristic thick gelatinous sputum from a viscid capsular polysaccharide |
|
what is the most frequent cause of gram-neg bacterial pneumonia?
|
Klebsiella pneumoniae
|
|
Pseudomonas aeruginosa
|
gram-negative bacillus
causes community-acquired pneumonia in cystic fibrosis patients; in other groups is more often a nosocomial pneumonia common cause of pneumonia in neutropenic patients likes to invade vessels and spread outside of the lungs, causing very fulminant septicemia |
|
Legionella pneumophila
|
causes Legionnaires' disease
causes Pontiac fever (self-limiting URI) tends to be found in water sources (cooling towers or tubing systems for domestic water supplies) causes pneumonia in pts with other medical ailments (transplant pts and immunosuppressed pts) mortality is up to 50% in immunosuppressed pts |
|
what are the two patterns of bacterial pneumonia?
|
(1) bronchopneumonia (lobular) pattern
- patchy consolidation of acute suppurative inflammation - caused by any organism, but most commonly P. aeruginosa (can be caused by S. aureus, S. pneumoniae, H. influenzae, coliforms) (2) lobar pneumonia pattern - infection of entire lobe (or at least a large part of one) - usually (90-95%) caused by S. pneumoniae |
|
bronchopneumonia pattern of bacterial pneumonia
|
lobular pattern formed by patchy consolidations of acute suppurative inflammation often extending to multiple lobes and/or bilateral lungs; tends to be basal b/c that's where the secretions gravitate
usually an extension of preexisting bronchitis/bronchiolitis seen in infancy and in old age (can be a terminal event in old age) any organism can produce this pattern, but P. aeruginosa is especially known for it and S. aureus, S. pneumoniae, and H. influenzae are common causes |
|
morphology of bronchopneumonia pattern of bacterial pneumonia
|
gross - patchy, dry, granular, 3-4cm, grey-red to yellow consolidations of suppurative inflammation with poorly demarcated edges
micro - neutrophilic exudate in bronchi, bronchioles, and adjacent alveoli |
|
lobar pneumonia pattern of bacterial pneumonia
|
infection of an entire lobe or at least a large part of one
may have associated pleuritis b/c the pleura is often involved (fibrinous rxn to underlying inflammation; may completely resolve or leave some fibrous thickening/adhesions) 90-95% caused by S. pneumoniae b/c the capsule is protective (type 3 is particularly virulent) - occasionally caused by K. pneumoniae, P. aeruginosa, P. mirabilis 4 stages: (1) congestion (2) red hepatization (3) grey hepatization (4) resolution |
|
what are the four stages of the lobar pattern of bacterial pneumonia?
|
(1) congestion - lung is heavy, boggy, and red and bacteria, but few WBCs are present (congestion and intra-alveolar accumulation of fluid)
(2) red hepatization - lung is firm, red, and airless (resembles liver); massive confluent exudation of wbcs, rbcs, and fibrin that completely fill alveolar spaces (3) grey hepatization - lung is pale grey-brown, and dry; disintegration of rbcs and fibrinopurulent exudate persists (4) resolution - exudate is enzymatically digested, resorbed by macrophages, and subsequently coughed up |
|
what are the complications of pneumonia?
|
abscess (esp with K. pneumoniae and type 3 pneumococcus)
empyema (diffuse or localized spread of inflammation to pleural cavity) fibrosis (organization without clearing) dissemination to other organs (heart valves/brain) |
|
clinical features of bacterial pneumonia
|
productive cough
abrupt high fever and chills pleuritic pain and friction rub |
|
what is the most common organism that causes community acquired atypical pneumonia?
|
mycoplasma
|
|
what are the viral causes of pneumonia?
|
influenza A & B
respiratory syncytial virus adenovirus, rhinovirus rubeola, varicella chlamydia pneumoniae, coxiella burnetti |
|
gross morphology of atypical community acquired pneumonia
|
variable distribution (patchy or lobar)
lungs red-blue, congested, and subcrepitant (less air) pleuritis is infrequently associated with atypical pneumonia **lack of alveolar exudate** **no consolidation** **moderate inc. in wbcs** |
|
microscopic morphology of atypical community acquired pneumonia
|
interstitial pneumonia b/c inflammation is confined within the alveolar septae rather than exuding into alveolar spaces
wide, edematous septae mononuclear inflammation (lymphocytes) causes alveolar-capillary block so that the air can't travel well may or may not be proteinaceous material in alveolar space (may form hyaline membranes) pt may have superimposed bacterial infection (esp. with flu virus) |
|
clinical features of atypical community acquired pneumonia
|
variable from severe "chest cold" (walking pneumonia) to fatal disease, but is usually mild disease with very low mortality
may/may not have cough that produces moderate sputum symptoms are out of proportion to clinical findings (i.e. pt can't catch their breath, but their lungs sound ok - b/c of alveolar-capillary block air can't travel well) cold agglutinins present in serum of 50% of pts with mycoplasma pneumonia and of 20% of pts with adenoviral pneumonia |
|
influenza virus
|
single-stranded RNA virus
nucleoproteins determine type (A/B/C) and surface lipid envelope containing hemaglutinin and neuraminidase determine subtype (H1-3 & N1-2) type A is a major cause of epidemic and pandemic infections (b/c of genetic drift/shift respectively) types B and C do not have genetic drift so they mostly infect children (one infection confers immunity) |
|
what is the function of hemagglutinin in the surface lipid envelope of influenza viruses?
|
binds to sialic acid-containing proteins and lipids on host cells
mediates entry into cells |
|
what is the function of neuraminidase in the surface lipid envelope of influenza viruses?
|
cleaves sialic acid residues from proteins and lipids on infected host cells so that new virions can be released from the host cells
|
|
against what parts of the influenza virus does the host make antibodies?
|
hemagglutinin
neuraminidase **useful for vaccines - use the strains of flu that are prevalent in the winter months of the opposite hemisphere** |
|
antigenic drift vs. antigenic shift in influenza A virus
|
drift: caused by mutations of hemagglutinin and neuraminidase
- causes epidemic infections shift: caused by replacement of both hemagglutinin and neuraminidase through recombination of RNA segments with those of animal viruses - causes pandemic infections - humans have no protection |
|
how is the influenza virus cleared from host cells?
|
cytotoxic T cells kill infected host cells
IFNalpha and IFNbeta stimulate macrophages to induce synthesis of Mx1, an intracellular anti-flu protein |
|
avian flu
|
influenza virus type A H5N1
60% mortality in humans spreads in wild/domestic birds/chickens and so far transmission is inefficient, but the fear is antigenic recombination with a flu strain highly infectious to humans - virulent strains cause widespread infection (not just in the lung) because of its unusual hemagglutinin pattern that can be cleaved by ubiquitous proteases, allowing entry into and damage of cells of many organs - less virulent strains are only cleaved by specific proteases in limited organs, esp. the lung |
|
morphology of influenza virus infection
|
UPPER RESPIRATORY:
- mucosal hyperemia and swelling - lymphoplasmacytic infiltrate - excess mucus is secreted, which can cause plugging and lead to secondary baterial infection - can get viral-induced tonsillitis in children LOWER REPIRATORY: - vocal cord swelling - excessive mucus plugging leading to secondary bacterial infection of lung and/or atelectasis - if more severe, causes accumulation of cell debris, fibrin, and inflammatory cells with obliterative bronchiolitis and permanent lung damage |
|
human metapneumovirus
|
negative-sense single-stranded RNA of the paramyxovirus family
mostly causes URIs and LRIs in young children, the elderly, and the immunocompromised - up to 20% of office/clinic resp. infections - 5-10% of hospitalizations for resp. infections in kids - clinically resembles RSV - can get reinfections throughout life, especially in old people doesn't culture well, so use PCR |
|
severe acute respiratory syndrome (SARS)
|
travel-related atypical pneumonia caused by the SARS coronavirus (a positive-sense, enveloped RNA virus)
incubation period: 2-10 days Sx: dry cough, malaise, myalgia, fever, chills 1/3 of pts improve; 2/3 progress to severe respiratory disease; 10% die Dx: PCR detection of virus or by appearance of Abs (viral load peaks at 10 days but Abs may not be detected for 28 days) Tx: no specific treatment |
|
history of SARS
|
started in China (first cases probably caused by contact with civets, a type of wild cat), spread through parts of SE Asia, and then to Toronto; travel related
in 6 months, there were more than 8,000 cases and 775 deaths |
|
nosocomial pneumonia
|
pulmonary infections acquired in the course of a hospital stay
often found in sick/immunosuppressed pts pts on a ventilator are at a particularly high risk b/c the ventilator bypasses the defenses of the URT common causative organisms: gram-neg rods (P. aeruginosa, enterobacteriaceae); S. aureus S. pneumoniae is NOT a common pathogen to cause nosocomial pneumonia |
|
aspiration pneumonia
|
common in debilitated or unconscious patients with repeated vomiting or abnormal gag/swallowing reflexes
combination of chemical pneumonia from stomach acid and bacterial pneumonia from oral flora usually more than one organism (aerobes>anaerobes) is recovered from samples of sputum, etc. can be fulminant and cause death, or can cause a lung abscess |
|
what is the frequent complication of aspiration pneumonia?
|
abscess formation
|
|
what is an abscess?
|
localized suppuration characterized by necrosis of tissue
|
|
what organisms cause abscesses in the lungs?
|
S. aureus
S. pneumoniae P. aeruginosa & other gram-neg bacteria anaerobes from the oral cavity |
|
mechanisms of abscess formation
|
1) aspiration of infective material (most common cause)
- alcoholics - gingivodental sepsis - condition that depresses cough reflex - aspiration of gastric contents 2) antecedent bacterial infection (pneumonia) - Klebsiella, S. aureus, type 3 Pneumococcus - fungi 3) septic embolus from veins or right heart valves that travels to and becomes lodged in the lungs 4) neoplastic obstruction 5) primary cryptogenic abscess (no explanation for why it is there) |
|
gross morphology of an abscess
|
range in size from mm's to 5 or 6 cm
if caused by aspiration, most often there is a single abscess on the right side pneumonic/bronchiectatic abscesses are generally multiple and located in the basal regions can be filled with debris or not, depending whether or not it can drain into air passages; if it is filled, often get a saprophytic (organisms that live off of dead material) infection also can enlarge to be multilocular cavities (gangrene of the lungs) |
|
microscopic morphology of an abscess
|
suppurative (accumulation of neutrophils) destruction of lung parenchyma
central cavitation with a rim of fibrous tissue |
|
clinical features of abscesses
|
similar to bronchiectasis - cough & purulent sputum, fever, chest pain, weight loss, digital clubbing
in 10-15% of older patients, there is an underlying carcinoma (central tissue destruction with secondary abscess formation) complications: spread to pleura/brain; amyloidosis (AA type) |
|
chronic pneumonia
|
localized lesion in an immunocompetent pt with or without lymph node involvement
caused by TB or fungi (histoplasmosis/blastomycosis/coccidioidomycosis) - chronic fungal pneumonia causes a granulomatous lung disease that resembles TB |
|
histoplasmosis
|
caused by Histoplasma capsulatum (a thermally dimorphic fungus that infects macrophages)
yeast forms are phagocytosed by unstimulated macrophages, proliferate in the phagolysosome, and then lyse the host cell infection is controlled by CD4 cells recognizing fungal cell wall antigens and heat shock proteins - CD4 cells secrete IFNgamma to activate macrophages to kill yeast - yeast stimulates TNF secretion by macrophages, which stimulates other macrophages to kill the organism associated with inhalation of dust from soil contaminated with infected bird/bat droppings common fungus in the Ohio-Mississippi river basins and the Caribbean major opportunistic infection in patients with AIDS because they lack cellular immunity |
|
similarities and differentiation of histoplasmosis to TB
|
similarities to TB:
- self-limited primary pulmonary involvement (coin lesions) with progressive secondary lung disease in the apices - Sx: cough, fever, night sweats - localized extra-pulmonary lesions - disseminated disease in immunosuppressed HOW TO DIFFERENTIATE: - histoplasmin test (+ in histoplasmosis) - ID organism in biopsy (not sputum) - serologic tests |
|
morphology of histoplasmosis in otherwise healthy individuals
|
healthy people: granulomas with caseous necrosis coalesce, producing large areas of consolidation or occasionally liquefy into cavities
lesions fibrose and calcify to give a tree bark appearance (concentric lamination) organism may persist for years in the 3-5um thin walled yeast form |
|
morphology of histoplasmosis in chronic disease
|
granulomas with caseous necrosis in the apex of the lung and/or in the hilar lymph nodes
progressively involves more and more of the lung less cavity formation than in TB |
|
morphology of histoplasmosis in fulminant, disseminated disease state
|
**present in immunosuppressed pts**
no granulomas form macrophages filled with H. capsulatum organisms accumulate in multiple organs (not just the lung) |
|
blastomycosis
|
caused by Blastomyces dermatidis (a soil inhabiting, thermally dimorphic fungus)
common in the central and SE United States, Canada, Mexico, Middle East, Africa, and India organism is very difficult to isolate takes three forms (1) pulmonary disease (2) rare primary cutaneous form from direct inoculation (3) disseminated disease |
|
pulmonary disease caused by Blastomyces dermatidis
|
abrupt onset of a productive cough, chest pain, fever, night sweats, chills, headache, chest pain, and abdominal pain
can have multilobular, perihilar, or miliary infiltrates, or multiple discrete nodules - upper lobes are most often involved see suppurative granulomas; macrophages have limited kill ability, so the organism persists and recruits neutrophils can resolve, persist, or progress to chronic disease |
|
how does Blastomyces dermatidis appear in tissue?
|
5-15um organisms with broad-based round budding and a thick, double-contoured wall
|
|
primary cutaneous disease caused by Blastomyces dermatidis
|
rare
caused by direct inoculation marked epithelial hyperplasia (mimicks squamous cell carcinoma) |
|
coccidioidomycosis
|
caused by Coccidioides immitis (encapsulated fungus)
common in the SW and far west US, as well as Mexican nearly everyone who inhales spores are infected (80% of ppl who live in endemic areas have pos. skin test) but most primary infections are asymptomatic - 10% present with fever, cough, pleurisy, skin lesions, and lung lesions (San Joaquin Valley Fever) - <1% present as disseminated infection affecting the skin and meninges infective forms block phagosome/lysosome fusion so that they are resistant to intracellular killing |
|
San Joaquin Valley Fever
|
airborne fungal infection caused by Coccidioides immitis (aka coccidioidomycosis)
presents with fever, cough, hemoptysis, pleurisy, skin lesions and lung lesions |
|
morphology of coccidioidomycosis
|
granulomas are thick-walled spherules 20-60um filled with endospores
pyogenic rxn on rupture arthrospores grown in culture are very infections rarely causes progressive multisystem disease |
|
pneumonia in immunocompromised (AIDS) patients
|
almost all get opportunistic infections, often Pneumocystis, but can also get "regular" infections (bacterial pneumonias are more common, more severe, and more often lead to bacteremia)
bacterial and TB infections are more likely with higher CD4 counts (>200) - pneumocystis generally infects with CD4 counts <200 (cup/helmet-shaped) - CMV and MAC generally infect with CD4 counts <50 not all infiltrates are pneumonias (kaposi sarcoma, lymphoma, etc.) |
|
lung transplants
|
usually get only one lung so that the other can go to another patient; exception is bilateral chronic infection
1YS is 75%; 5YS is 50%; 10YS is 25% infection prone can undergo acute or chronic rejection |
|
to what infections are lung transplants prone?
|
1) bacterial (most common in the first few weeks)
2) viral, esp. CMV (decreasing with prophylaxis; usually occurs btwn 3-12 mos) 3) pneumocystis (rare b/c of prophylaxis) 4) fungal (candida or aspergillus; common at the anastomosis btwn the lung and bronchi) |
|
what is the most common infection in the first few weeks after a lung transplant?
|
bacterial infection
|
|
acute rejection of lung transplant
|
occurs wks to mos after transplant or later if immunosuppression is decreased
clinically similar to infection (distinguish with a biopsy) mononuclear cell infiltrates around small vessels, in submucosa, or both responds to steroids |
|
chronic rejection of lung transplant
|
occurs in 50% of pts in 3-5 years
Sx: cough, dyspnea, irreversible dec. in PFTs bronchiolitis obliterans (obstruction of small airways by fibrosis with/without active inflammation) - often very patchy, so a biopsy may not show it cellular rejection around vessels |
|
pulmonary carcinomas
|
90-95% of lung neoplasms (most frequent fatal malignancy) 85% of lung carcinomas are in smokers or those who have recently quit
highly associated with smoking in males, the incidence & mortality is declining; in females, incidence has plateaued by mortality is still increasing most common btwn 40 and 70 years old, peaking in 50s-60s 1YS=41%; 5YS=15% |
|
pathogenesis
|
smoking is the biggest risk factor
- correlated with the amount of daily smoking, the duration of smoking, and the inhalation of smoke - 10 yrs after quitting, risk is less, but still not to baseline - cigar and pipe smoking inc. risk some, but not as much women have greater susceptibility to tobacco carcinogens 97% of smokers have atypical cells in bronchial tree (vs. 1% of non-smokers) |
|
how does smoking affect the risk of developing a pulmonary carcinoma?
|
average smoker has 10x risk
heavy smoker (2 packs/day) has 60x risk |
|
what are the risk factors for developing pulmonary carcinomas?
|
smoking
radiation asbestos radon in homes |
|
what is the most frequent malignancy in asbestos exposure?
|
lung cancer
latency of 10-30 years |
|
what dominant oncogenes are frequently involved in pulmonary carcinomas?
|
c-MYC
K-RAS (non-small cell carcinoma) EGFR (non-small cell carcinoma) c-MET c-KIT (overexpressed, not mutated, in small cell carcinoma) |
|
what tumor suppressor genes are commonly deleted in pulmonary carcinomas?
|
p53 (small cell and non-small cell)
RB (small cell carcinoma) p16/INK4alpha (non-small cell carcinoma) |
|
what are the genetic predispositions to pulmonary carcinomas?
|
some alleles of CYP1A1 increase the ability to metabolize some precarcinogens, increasing risk of cancer
pts with lymphocytes that have chromosome breaks on exposure to tobacco carcinogens |
|
if not associated with smoking, in what gender are pulmonary carcinomas more frequent?
|
women
mostly associated with EGFR mutations; KRAS & p53 mutations less so |
|
what mutations are common in small cell lung carcinoma?
|
MYCN*
MYCL* p53 3p RB BCL2* c-KIT* *= oncogenes |
|
what mutations are common in non-small cell lung carcinoma
|
EGFR*
KRAS* p53 p16/INK4alpha *=oncogenes |
|
what are the precursors for lung carcinomas?
|
squamous metaplasia
atypical metaplasia dysplasia carcinoma in situ |
|
what percentages of lung carcinomas are squamous cell? adenocarcinomas? small cell? large cell?
|
type - M - F
squamous - 32% - 25% adeno - 37% - 47% small cell - 14% - 18% large cell - 18% - 10% |
|
what is the most common form of lung carcinomas?
|
adenocarcinoma
been increasing for past 20 years, until they are now the most common form, especially in females |
|
where do carcinomas tend to arise?
|
in general, carcinomas tend to be central lesions, originating in the first-third order bronchi
they are more common closer to the hilus of the lungs smaller numbers arise in the periphery, from alveolar septal cells or terminal bronchioles; these tend to be adenocarcinomas |
|
information about the development of lung carcinomas in general
|
start as cytological atypia and progress to thickening or piling up of abnormal mucosa
excrescence that elevates or erodes lining epithelium finally, several scenarios can occur: 1) grow into lumen of the bronchus and cause obstruction 2) penetrate into wall of bronchus and infiltrate peribronchial tissue into adjacent regions of the carina or mediastinum 3) grow into the parenchyma forming a broad intraparenchymal mass |
|
gross morphology of lung carcinomas
|
firm or hard
grey-white see hemorrhage or necrosis, especially when large (appear yellow-white and soft) large tumors can cavitate at necrotic foci |
|
extension of lung carcinomas
|
can breach pleura or pericardium
more than 50% have bronchial, hilar, or mediastinal node involvement |
|
distant spread of lung carcinomas
|
lymphatic and hematogenous spread
spread early in the course of the tumor, except for squamous cell carcinoma which metastasizes outside the thorax late in the course >50% have adrenal involvement 30-50% have liver involvement 20% have brain involvement 205 have bone involvement |
|
what characteristics are associated with patients who have squamous cell carcinoma of the lung?
|
males
smokers |
|
gross morphology of squamous cell carcinoma of the lung
|
tends to be central and located in large bronchi; peripheral forms are increasing in frequency
tumors are large in general, local spread, but rapid growth counteracts the later metastases metastases form later in the clinical course than in other types of lung carcinomas |
|
microscopic morphology of squamous cell lung carcinoma
|
can be:
1) well differentiated: - keratin and intercellular bridging 2) less differentiated: - mix or cannot distinguish from adenocarcinoma - MUST distinguish from small cell carcinoma |
|
molecular markers of squamous cell lung carcinoma
|
higher frequency of p53 mutations than other mutations
loss of protein expression of RB and p16/INK4a genes overexpression of EGFR HER-2/neu is highly expressed |
|
general information about lung adenocarcinomas
|
malignant epithelial tumor with glandular differentiation or mucin production
most common lung carcinoma, especially in females and non-smokers slower growing than squamous cell carcinoma, but metastases are early and widely-spread located more peripherally than are squamous cell carcinomas and are smaller can be associated with a scar |
|
though adenocarcinomas are commonly associated with non-smokers, what percent of them are in smokers?
|
75%
filters and low tar/nicotine in cigarettes allow for deeper inhalation, exposing more peripheral airways to the carcinogens |
|
microscopic morphology of lung adenocarcinomas
|
vary from well-defined glands to papillary tumors to solid tumors with only a few mucin-producing cells
80% form and secrete mucin most adenocarcinomas are TTF (thyroid transcription factor)-positive |
|
molecular markers of lung adenocarcinomas
|
K-RAS mutations (associated with worse outcome and resistance to EGFR inhibitors)
p53 mutations RB mutations p16 mutations |
|
what pulmonary adenocarcinoma molecular marker is associated with a worse outcome and resistance to EGFR inhibitors?
|
K-RAS mutations
EGFR mutations have improved survival if treated with EGFR inhibitors |
|
bronchioloalveolar subtype of pulmonary carcinomas are a subtype of what type of lung carcinoma?
|
bronchioloalveolar carcinoma is a subtype of pulmonary adenocarcinoma that involves the pulmonary parenchyma in terminal bronchioalveolar regions
|
|
general information about the bronchioloalveolar subtype of pulmonary adenocarcinomas
|
subtype of adenocarcinomas that involves the pulmonary parenchyma in terminal bronchioalveolar regions that is probably derived from terminal bronchioles or the alveolar walls
constitutes 1-10% of lung cancers if the lesion causes a dimple, it is more likely metastatic than primary; if the lesion causes a pucker in the lung, it is more likely primary than metastatic |
|
gross morphology of bronchioloalveolar subtype of adenocarcinoma
|
located peripherally
can be one nodule, multiple nodules, or coalescent (looks more like pneumonia than a tumor) parenchymal nodule is grey to grey-white, and depending on mucus production may or may not be translucent (translucent if mucus production is higher) |
|
microscopic morphology of bronchioloalveolar subtype of adenocarcinoma
|
grows along pre-existing structures without destroying alveolar architecture (lines the alveolar sacs)
non-mucinous are formed by columnar or cuboidal cells; they tend to be peripheral nodules, amenable to excision (excellent 5YS) mucinous are formed by tall columnar cells with cytoplasmic and intra-alveolar mucin; tend to spread aerogenously, with satellite tumors classic adenocarcinoma can have bronchioloalveolar pattern at periphery |
|
clinical features of bronchioloalveolar subtype of pulmonary adenocarcinomas
|
present anywher from 20s to late adulthood with equal sex distribution
presents with cough, hemoptysis, and pain since it does not invade bronchi, no atelectasis/obstruction is seen (noninvasive tumor, so it kills by suffocation) |
|
large cell carcinoma
|
10-15% of lung carcinomas
probably undifferentiated squamous cell or adenocarcinomas one variant is a large cell neuroendocrine carcinoma - organoid nesting, trabecular or rosette-like - ultrastructural features of neuroendocrine glands - 5YS is 27%; 10YS is 9% |
|
microscopic morphology of large cell carcinoma
|
probably undifferentiated squamous cell or adenocarcinoma
larger, polygonal cells that have large vesicular nuclei and prominent nucleoli; have moderate cytoplasm ultrastructure may show minimal glandular or squamous features |
|
small cell carcinoma of the lung
|
aka oat cell carcinoma
20-25% of pulmonary carcinomas highly malignant tumor of neuroendocrine origin, located in the hilar-to-central region of the lung no precursor lesions (doesn't start out as carcinoma in situ) can secrete various polypeptide hormones - common cause of paraneoplastic syndromes HIGH association with cigarette smoking (only 1% occur in non-smokers) |
|
microscopic morphology of small cell carcinoma of the lung
|
small (about 2x the size of a lymphocyte), round cells with little cytoplasm; the nucleus is filled with fine granular chromatin (in a salt & pepper pattern)
neuroendocrine markers are present on cells cells have a high mitotic rate and nuclear molding is prominent necrosis is a common feature, as is the "crush artifact" |
|
molecular mutations in small cell lung carcinoma
|
p53 mutations in 50-80%
RB mutations in 80-100% |
|
clinical features of small cell lung carcinomas
|
most aggressive lung tumors (if untreated, leads to rapid death in 6-16 weeks)
pts with these tumors are not surgical candidates metastases form early (most by time of dx); these carcinomas generally respond to radiotherapy/chemotherapy, but will recur commonly see paraneoplastic syndromes 5YS = 9%, 10YS = 5% |
|
combined pulmonary carcinomas
|
10% of lung carcinomas have histology of two or more carcinoma types
small cell carcinoma component non-small cell component |
|
what changes in lung, distal to obstruction, are seen as secondary pathology to lung carcinomas?
|
atelectasis (total obstruction)
emphysema (partial obstruction) bronchitis or bronchiectasis due to impaired airway drainage abscess |
|
what forms of secondary pathology are common to lung carcinomas?
|
changes in lung distal to obstruction
superior vena cava syndrome pancoast tumors |
|
superior vena cava syndrome
|
compression of superior vena cava (commonly caused by pulmonary carcinomas), which causes circulatory compromise
Sx: dusky head and arm, with edema (venous congestion of head and arm) |
|
pancoast tumors
|
apical carcinomatous lesions in the superior pulmonary sulcus
these lesions tend to invade neural structures around the trachea, including the cervical sympathetic plexus see Horner syndrome (ptosis, miosis, enophthalmos, anhidrosis) on the side of the lesion and severe pain in an ulnar nerve distribution |
|
clinical course of pulmonary carcinomas
|
common presenting symptoms: cough>wt loss>chest pain>dyspnea
central lesion dx by sputum cytology peripheral lesion dx by FNA can have the metastasis causing presentation (70-80% are not localized enough to be surgical candidates) 5YS=15% (if localized enough to be resected, 50% survival unless small cell) |
|
what paraneoplastic syndrome is caused by ADH?
|
inappropriate ADH with hyponatremia
|
|
what paraneoplastic syndrome is caused by ACTH?
|
Cushing syndrome
|
|
what paraneoplastic syndrome is caused by PTH or PTH-related peptide?
|
hypercalcemia
|
|
what paraneoplastic syndrome is caused by calcitonin?
|
hypocalcemia
|
|
what paraneoplastic syndrome is caused by gonadotropins?
|
gynecomastia
|
|
what paraneoplastic syndrome is caused by serotonin?
|
carcinoid syndrome
|
|
what paraneoplastic syndrome is caused by bradykinin?
|
carcinoid syndrome
|
|
what paraneoplastic syndromes are commonly caused by small cell lung carcinomas?
|
ADH - inappropriate ADH with hyponatremia
ACTH - Cushing syndrome serotonin - carcinoid syndrome bradykinin - carcinoid syndrome |
|
what paraneoplastic syndromes are commonly caused by squamous cell lung carcinomas?
|
PTH/PTH-related protein - hypercalcemia
|
|
what paraneoplastic syndromes are commonly caused by carcinoid lung tumors?
|
serotonin - carcinoid syndrome
bradykinin - carcinoid syndrome |
|
Lambert-Eaton Myasthenic Syndrome (LEMS)
|
muscle weakness caused by autoantibodies against neuronal calcium channels
around 60% of those with LEMS have an underlying malignancy, most commonly small cell lung cancer and is therefore regarded as a paraneoplastic syndrome |
|
leukemoid reaction
|
elevated WBC count (leukocytosis) that is a physiological response to stress or infection as opposed to a primary blood malignancy/leukemia
can be a paraneoplastic syndrome caused by primary lung cancers |
|
hypertrophic pulmonary osteoarthropathy
|
aka Bamberger-Marie disease
clubbing of fingers and periostitis of the long bones of the upper and lower extremities distal expansion of the long bones as well as painful, swollen joints and synovial villous proliferation are often seen may be primary or may be a secondary paraneoplastic syndrome caused by diseases like lung cancer |
|
pulmonary neuroendocrine cell hyperplasia
|
lesion that is secondary to airway fibrosis and/or inflammation
|
|
diffuse idiopathic neuroendocrine cell hyperplasia
|
rare pulmonary precursor lesion to multiple tumorlets and carcinoid tumors
|
|
neuroendocrine tumorlets
|
small, inconsequential hyperplastic nests of neuroendocrine cells in areas of scarring or inflammation
|
|
bronchial carcinoid
|
1-5% of lung tumors
usually present in patients younger than 40 years with equal distribution between the sexes no environmental associations, including smoking low-grade malignant lesions of epithelial origin that can be central or peripheral in the lungs occasionally part of MENs |
|
gross morphology of bronchial carcinoid
|
central lesions are spherical or occasionally finger-like masses usually no more than 4cm in diameter with intact mucosa that project into the lumen of a bronchus (usually main stem bronchi); less frequently they grow inward in peribronchial tissue as a collar button lesion (fan out in the peribronchial tissue)
peripheral lesions are solid and nodular |
|
microscopic morphology of bronchial carcinoid
|
nests, cords, and masses of cells separated by delicate stroma
cells have uniform, round nuclei and moderate amounts of cytoplasm (they contain dense-core granules characteristic of neuroendocrine cells, serotonin, neuron-specific enolase, calcitonin, and other peptides) rare mitoses are noted if these lesions become more pleomorphic, they tend to behave more aggressively |
|
atypical bronchial carcinoids
|
more likely to spread to lymph nodes than are other bronchial carcinoids
2-10 mitoses/hpf foci of necrosis p53 mutations, and abnormalities of BCL2 & BAX expression (not present in typical carcinoids) 5YS=56% 10YS=35% |
|
clinical features of bronchial carcinoids
|
cough, hemoptysis, and impairment of drainage with resultant sequelae are caused by the intraluminal growth
carcinoid syndrome (intermittent attacks of diarrhea, flushing, and cyanosis) is rare, but is caused by the serotonin secretion most follow a benign course and are resectable (10YS=85%); the atypical carcinoids can be locally invasive or metastasize (10YS=35%) |
|
pulmonary hamartoma
|
fairly common benign tumor made mostly of mature hyaline cartilage with some epithelial clefts
usually found as an incidental coin lesion (<4cm rounded focus of radioopacity) on Xray |
|
inflammatory pulmonary myofibroblastic tumor
|
rare tumor found in children
3-10cm grey-white round peripheral mass that consists of neoplastic fibroblasts, myofibroblasts, lymphocytes, and peripheral fibrosis seen as a round peripheral mass on Xray; 25% have calcifications visible on the Xray |
|
metastatic tumors in the lungs
|
the lungs are the most common site of metastasis from distant tumors; can also be invaded by neighbors (esophageal carcinomas and mediastinal lymphomas)
it is usual to have multiple discrete nodules, that tend to be peripheral, in all lobes (cannonball lesions) a less frequent clinical presentation would be diffuse infiltration of the septae and connective tissue (occurs with lymphatogenous spread) rarest presentation is seen in histology only as diffuse intralymphatic dissemination (no gross lesion is present) if they involve the subpleural lymphatics, it is called lymphangitis carcinomatosa |
|
lymphangitis carcinomatosa
|
diffuse infiltration and obstruction of pulmonary parenchymal lymphatic channels by tumor
involvement of subpleural lymphatics by metastases |
|
what is seen in the pleura as secondary involvement of an underlying disease?
|
lung infections and adhesions are most common
|
|
causes of effusions
|
inc. hydrostatic pressure (CHF)
inc. vascular permeability (pneumonia) dec. oncotic pressure (nephrotic syndrome) inc. intrapleural negative pressure (atelectasis) dec. lymphatic drainage (mediastinal carcinomatosis) |
|
inflammatory effusions
|
aka pleuritis
can be serous, serofibrinous, fibrinous caused by usual infections (pneumonia, TB, bronchiectasis, and abscess), by infarcts, by immune diseases, by radiation, or by metastatic disease usually fairly mild, with resolution more severe if empyema (frankly purulent exudate that consists of neutrophils) is formed |
|
what type of inflammatory effusion is caused by radiation?
|
serofibrinous pleuritis
|
|
empyema
|
inflammatory pleural effusion that consists of frankly purulent exudate (pus - formed by neutrophils)
usually caused by bacterial or fungal seeding of the pleural space as a contiguous spread from an intrapulmonary infection; less often caused by lymphatic/hematogenous seeding usually fairly small and localized, but harder than other effusions to resolve without formation of fibrous adhesions that can obliterate the pleural space/seriously restrict pulmonary expansion |
|
hemorrhagic effusions
|
suspect malignancy
can be caused by bleeding disorders or rickettsial disease |
|
hemothorax
|
noninflammatory pleural effusion that results from escape of blood into the pleural cavity, which forms large clots
caused by vascular trauma or ruptured aortic aneurysms |
|
hydrothorax
|
noninflammatory pleural effusion
clear, straw-colored fluid accumulated in the pleural space most common cause is CHF (leading to pulmonary congestion and edema) - usually presents bilaterally can be caused by ovarian fibroma and ascites (Meig syndrome) - presents unilateral on the right |
|
meig syndrome
|
triad of ascites, pleural effusion (hydrothorax), and benign ovarian tumor (fibroma)
for unknown reasons, the pleural effusion is classically unilateral, on the right side syndrome resolves after resection of the ovarian tumor |
|
chylothorax
|
noninflammatory pleural effusion
lymphatic fluid (chyle; milky white fluid) accumulated in the pleural space, more often seen on the left side must distinguish from turbid serous fluid by letting stand (chylous fat will separate, but the serous fluid will not) caused by thoracic duct trauma or lymphatic obstruction by a tumor |
|
what is a pneumothorax? what are the different kinds?
|
accumulation of air/gas in the pleural space
- spontaneous - traumatic - therapeutic - tension |
|
spontaneous pneumothorax
|
most often caused by rupture of an alveolus associated with emphysema, asthma, or TB, but can be associated with abscess
spontaneous idiopathic pneumothorax occurs in young people as the result of a rupture of small subpleural apical blebs commonly recurring |
|
traumatic pneumothorax
|
caused by perforating injury to the pleura (and sometimes to the lung)
air enters the lung from outside the body |
|
for what illness would a therapeutic pneumothorax be created?
|
used to be used as a treatment for TB
|
|
tension pneumothorax
|
caused by a ball valve effect in which air can enter the lung and/or pleural space with inspiration but cannot escape during expiration
progressive increase in pressure compresses the lung, mediastinum and opposite lung |
|
what type of tumors are more common in the pulmonary pleura?
|
secondary tumors are much more common than primary
lung and breast metastases are especially common (they create serous or serosanguinous effusions) |
|
what are the two types of primary pleural tumors?
|
solitary fibrous tumor (aka pleural fibroma) - benign
mesothelioma - malignant |
|
solitary fibrous tumor (pleural fibroma)
|
primary tumor of the visceral pulmonary pleura
usually a benign lesion, but rarely a non-benign tumor with necrosis, mitoses, and pleomorphism localized soft tissue tumor that lines the pulmonary pleura, ranges from a few cm to huge in size, and is often attached to the pleural surface by a pedicle (confined to the lung surface) no association with asbestos |
|
morphology of solitary fibrous tumor (pleural fibroma)
|
gross - dense fibrous tissue with occasional cysts filled with a viscid fluid
microscopic - whorls of reticulin and collagen with interspersed spindled cells looking like fibroblasts |
|
mesothelioma
|
malignant tumor that arises from either visceral or parietal pleura
90% are associated with occupational exposure to asbestos (risk with exposure to asbestos is 7-10%); smoking does NOT increase risk tumor takes 25-45 years after exposure to develop diffuse tumor, spreading widely in the pleural space, usually associated with effusion looks like the lung is sheathed in a thick layer of soft, gray-pink tumor |
|
microscopic morphology of mesothelioma
|
mixture of 2 types of cells (either of which can predominate)
1) mesenchymal cells - resembles a spindle cell sarcoma (sarcomatoid type) 2) epithelial cells - more common - cuboidal to columnar cells can form glandular or papillary structures difficult to distinguish from adenocarcinoma, especially if epithelial cells predominate characteristic EM appearance with long microvilli and many tonofilaments |
|
what distinguishing markers are useful to distinguish mesothelioma from adenocarcinomas?
|
acid mucopolysaccharide positive
negative for CEA and other adenocarcinoma markers staining for keratin proteins is perinuclear in mesothelioma and peripheral in adenocarcinoma immunohistochemistry: - positive for calretinin - positive for WT-1 - positive for cytokeratin 5/6 |
|
clinical features of mesothelioma
|
patient presents with chest pain, dyspnea, and effusion
tumor can directly invade the lung or have metastatic spread to hilar nodes, liver, or other distant organs pulmonary asbestosis is only present in 20% of cases 1YS=50%, few ppl survive >2yrs |
|
besides the pulmonary pleura, where can mesothelioma present?
|
peritoneum
- still related to asbestos exposure - intestinal involvement can lead to intestinal obstruction and death pt presents with inanition, defined as: - lack of mental or spiritual vigor and enthusiasm - exhaustion caused by lack of nourishment |